Page last updated: 2024-08-25

terlipressin and Systemic Inflammatory Response Syndrome

terlipressin has been researched along with Systemic Inflammatory Response Syndrome in 5 studies

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's3 (60.00)29.6817
2010's2 (40.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bajaj, JS; Boyer, TD; Escalante, S; Jamil, K; Pappas, SC; Sanyal, AJ; Wong, F1
Hofbeck, M; Kumpf, M; Michel, J; Neunhoeffer, F; Renk, H; Spiller, G1
Bone, HG; Ertmer, C; Sielenkämper, AW; van Aken, H; Westphal, M1
Traber, DL; Westphal, M1
Araújo, LV; Freitas, GG; Martins, GA; Salluh, JI; Santino, MS; Verdeal, JC1

Reviews

1 review(s) available for terlipressin and Systemic Inflammatory Response Syndrome

ArticleYear
[Vasopressin and terlipressin in sepsis and systemic inflammatory response syndrome. Effects on microcirculation, oxygen transport, metabolism and organ function].
    Der Anaesthesist, 2005, Volume: 54, Issue:4

    Topics: Animals; Humans; Lypressin; Microcirculation; Oxygen Consumption; Sepsis; Systemic Inflammatory Response Syndrome; Terlipressin; Vasoconstrictor Agents; Vasopressins

2005

Trials

1 trial(s) available for terlipressin and Systemic Inflammatory Response Syndrome

ArticleYear
Terlipressin Improves Renal Function and Reverses Hepatorenal Syndrome in Patients With Systemic Inflammatory Response Syndrome.
    Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association, 2017, Volume: 15, Issue:2

    Topics: Aged; Canada; Female; Hepatorenal Syndrome; Humans; Lypressin; Male; Middle Aged; Placebos; Retrospective Studies; Survival Analysis; Systemic Inflammatory Response Syndrome; Terlipressin; Treatment Outcome; United States; Vasoconstrictor Agents

2017

Other Studies

3 other study(ies) available for terlipressin and Systemic Inflammatory Response Syndrome

ArticleYear
Safety and Efficacy of Terlipressin in Pediatric Distributive Shock: A Retrospective Analysis in 20 Children.
    Paediatric drugs, 2017, Volume: 19, Issue:1

    Topics: Adolescent; Catecholamines; Child; Child, Preschool; Female; Heart Rate; Hemodynamics; Humans; Hypotension; Infant; Infant, Newborn; Lypressin; Male; Retrospective Studies; Shock; Systemic Inflammatory Response Syndrome; Terlipressin; Treatment Failure; Vasoconstrictor Agents; Young Adult

2017
Low-dose terlipressin for hemodynamic support in sepsis and systemic inflammatory response syndrome: art for (he)art's sake or state of the art?
    Critical care medicine, 2005, Volume: 33, Issue:2

    Topics: Animals; Hemodynamics; Humans; Liver Circulation; Lypressin; Sepsis; Splanchnic Circulation; Systemic Inflammatory Response Syndrome; Terlipressin; Vasoconstrictor Agents

2005
Early use of terlipressin in catecholamine-resistant shock improves cerebral perfusion pressure in severe traumatic brain injury.
    Acta anaesthesiologica Scandinavica, 2007, Volume: 51, Issue:4

    Topics: Accidents, Traffic; Adolescent; Blood Pressure; Brain Injuries; Catecholamines; Cerebrovascular Circulation; Drug Resistance; Fatal Outcome; Humans; Lypressin; Male; Motorcycles; Multiple Organ Failure; Norepinephrine; Oxygen; Respiratory Distress Syndrome; Severity of Illness Index; Shock; Systemic Inflammatory Response Syndrome; Terlipressin; Time Factors; Vasoconstrictor Agents

2007